H. Res. 1318 (119th)Bill Overview

Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".

Simple Resolutiondomestic policy
Cosponsors
Support
Lean Democratic
Introduced
May 21, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution is a statement by the House supporting the designation of May 2026 as Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month. It does not create new laws, authorize spending, or require federal agencies to take action. The text expresses support for research, recognition, and awareness, and it commends people and organizations working on these diseases. The effect is symbolic and meant to raise public awareness and encourage voluntary activities.

Passage rules

This is a simple resolution acted on by the House alone and does not go to the President or become law. It is non-binding and carries no legal force.

A House resolution expressing support for designating May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month," recognizing disease features and community impacts, endorsing research on diagnosis and treatments, and commending affected individuals, caregivers, researchers, and clinicians.

The resolution is symbolic and does not appropriate funds or create new programs.

Passage5/100

Very likely to pass the House as a resolution but H.Res. does not create binding law; becoming statutory law is unlikely absent separate bill.

CredibilityAligned

Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the awareness purpose and names a specific month, while appropriately avoiding substantive legal changes or funding commitments.

Contention10/100

Progressive seeks concrete funding and equity measures

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitIncreases public awareness, potentially improving earlier recognition and clinical referrals for affected individuals.
  • Potential benefitEncourages researchers and institutions to prioritize PSP and CBD study and grant applications.
  • Potential benefitSupports outreach to patients and caregivers, facilitating dissemination of information and available resources.
Likely burdened
  • Federal agenciesResolution is symbolic and does not authorize funding, regulation, or mandated federal programs.
  • Federal agenciesCould raise expectations for federal action without accompanying appropriations or concrete plans.
  • Potential burdenLimited measurable impact on disease incidence, treatment development, or clinical outcomes by itself.
03 · Why people split

Why the argument around this bill splits.

Progressive seeks concrete funding and equity measures
Progressive90%

Generally supportive of the awareness designation and its emphasis on research and caregiver needs.

Views the resolution as a positive step but would prefer explicit commitments to funding, equitable access, and research priorities aimed at care and cures.

Leans supportive
Centrist95%

Supportive of a nonbinding resolution that raises awareness and encourages research, while noting it lacks specifics on funding, metrics, or implementation.

Sees value in honoring affected families and clinicians but wants clarity on next steps and fiscal implications.

Leans supportive
Conservative80%

Likely to view the resolution as a benign, sympathetic symbolic recognition of patients and caregivers.

Some concern may exist about federal overreach if expectations shift toward new spending or mandates, but the nonbinding nature reduces opposition.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood5/100

Very likely to pass the House as a resolution but H.Res. does not create binding law; becoming statutory law is unlikely absent separate bill.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether House leadership will allocate floor time for the resolution
  • If sponsors seek a companion Senate resolution
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressive seeks concrete funding and equity measures

Very likely to pass the House as a resolution but H.Res. does not create binding law; becoming statutory law is unlikely absent separate bi…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the awareness purpose and names a specific month, while appropriately avoiding substantive le…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis